Speaker:
Kelly Hong


Learning Objectives:

  • Describe the pathophysiology of atrial fibrillation and modifiable risk factors
  • Utilize CHA2DS2VASC and other thromboembolic risk assessment tools to classify patients' risk for stroke
  • Analyze and implement appropriate management strategies from the 2023 atrial fibrillation guidelines in a patient case


Disclosure:
Kelly has no relevant financial relationships to disclose.

Session date: 
10/31/2024 - 2:00pm to 3:00pm EDT
  • 1.00 ACPE Pharmacy
  • 1.00 Participation
Please login or register to take this course.